InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by 박창익, 首席执行官. Officer active across 2 companies, notably 삼진제약. Aggregated, 2 reports have been recorded. Activity tracked since 13 April 2026. The latest transaction was filed on 13 April 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Park Chang-ik is the Executive Director at 삼진제약, a pharmaceutical company. In this role, he is responsible for managing operations and implementing the company's strategies. His leadership is essential for the development and growth of 삼진제약.